Safety & Efficacy of drugs, drug-device combinations.

MVT in Silico, A Human Relevant Life Sciences Pre-Clinical R&D Company

At MVT in Silico, we redefine pre-clinical R&D for drug development & drug-device combination development through the use of non-animal technologies that are more cost effective and reduce R&D cycles. The outcome of our approach is a more efficient and reliable path to bringing new human trearments to clinical trials and eventually to market.

Our Vision

Clinical trials are very expensive. Our indication agnostic platform technology is designed to transform current pre-clinical R&D practices that de-risks downstream clinical trials.

Our Mission

We are committed to ensuring the safety & efficacy of treatments. We are on a mission to eliminate avoidable costs, delays, and achieve greater reliability for new treatments.